Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
MIRA Pharmaceuticals, Inc. (MIRA) had Income from Continuous Operations of $-1.78M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.78M |
|
-- |
|
-- |
|
$1.81M |
|
$-1.81M |
|
$0.02M |
|
$-1.78M |
|
$-1.78M |
|
$-1.78M |
|
|
Income from Continuous Operations |
$-1.78M |
$-1.78M |
|
$-1.78M |
|
$-1.81M |
|
$-1.81M |
|
16.65M |
|
16.65M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$1.36M |
|
-- |
|
$0.04M |
|
$1.40M |
|
$0.11M |
|
-- |
|
-- |
|
$0.11M |
|
$1.29M |
|
$1.29M |
|
$1.29M |
|
16.81M |
|
| Cash Flow Statement Financials | |
$-1.63M |
|
-- |
|
$0.00M |
|
$2.83M |
|
$1.21M |
|
$-1.63M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-137.83% |
|
-137.83% |
|
-127.38% |
|
-137.83% |
|
$0.08 |
|
$-0.10 |
|
$-0.10 |
|